Bio Medica Laboratories Limited
Integrated Filing- Financial
01 / The disclosure
What the company shared
Un-Audited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the half year ended September 30, 2026 in terms of Regulation 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) 2015.
A question for your research
Check the reporting period, standalone versus consolidated basis, units and prior-period comparability before using financial figures.
Disclosed period ended 2026-09-30 · Q2 FY2027The evidence
Read the source excerpts
PDF text is unavailable. Read the original filing for the full disclosure.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106859185
- First collected
- 13 Nov 2026, 17:41 IST
- PDF extraction
- metadata_only